Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia
Open Access
- 3 September 2011
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 30 (3) , 419-426
Abstract
Objective This study’s aim was to describe and evaluate outcomes of medical strategies used for lower urinary tract symptoms (LUTS) treatment in general practice and to assess impact of LUTS on patients’ general health-related quality of life (HRQoL). Methods This cross-sectional observational study was conducted by French general practitioners. Eligible patients were males aged ≥50 years, diagnosed for at least one year and currently treated for LUTS due to benign prostatic hyperplasia (BPH). Several validated questionnaires were documented by patients to assess severity of LUTS (IPSS), specific quality of life (IPSS-Q8), impact of LUTS (BII), LUTS evolution (VNS) and general HRQoL (EQ-5D). Results Among 1,098 patients included, 82.7% were treated with monotherapies and 17.3% with combinations. Mean treatment duration was 5.2 ± 3.2 years, and 47.2% of patients had at least one treatment modification since initiation. Patients reported diminished quality of life (IPSS-Q8 ≥3) (42.3%), persisting symptoms (IPSS-score ≥12) (35.5%), symptoms worsening (VNS-score ≤−1) (18.8%) and high bother (BII-score ≥9) (2.6%). Globally, 52.8% had at least one of these unsatisfactory outcomes. Regarding general HRQoL, mean EQ-5D utility significantly decreased with LUTS severity (mild: 0.90 ± 0.12; moderate: 0.81 ± 0.21; and severe symptoms: 0.73 ± 0.25; P < 0.001). As well, all five-dimensions of EQ-5D were significantly altered in patients with moderate-to-severe LUTS (<0.001), especially ‘Pain/Discomfort’ and ‘Anxiety/Depression’. In multivariate analyses including age and comorbidities, EQ-5D utility index remained negatively associated with each additional unit in the IPSS-score. Conclusions This study shows that around half of BPH patients medically treated report unsatisfactory outcomes, suggesting consequential unmet medical needs in general practice. Also, moderate-to-severe LUTS significantly impact on general HRQoL.Keywords
This publication has 28 references indexed in Scilit:
- 2010 Update: Guidelines for the management of benign prostatic hyperplasiaCanadian Urological Association Journal, 2010
- Impact of Lower Urinary Tract Symptoms on Discomfort in Men Aged between 50 and 80 YearsUrologia Internationalis, 2010
- UT1 VALUING EQ-5D USING TIME TRADE-OFF IN FRANCEValue in Health, 2009
- The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptomsHealth and Quality of Life Outcomes, 2009
- Adherence to monthly and weekly oral bisphosphonates in women with osteoporosisOsteoporosis International, 2009
- The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health‐related quality of life, anxiety and depression: EpiLUTSBJU International, 2009
- Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countriesBJU International, 2008
- Self‐assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tractBJU International, 2005
- The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its managementBJU International, 2004
- Prevalence of distress and symptom severity from the lower urinary tract in men: a population-based study with the DAN-PSS questionnaireFamily Practice, 2004